Captor Capital Corp. (CSE:CPTR)
0.2600
0.00 (0.00%)
At close: Feb 27, 2026
Captor Capital Revenue
Captor Capital had revenue of 224.38K CAD in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to -1.18M. In the fiscal year ending March 31, 2025, Captor Capital had annual revenue of -1.74M.
Revenue (ttm)
-1.18M
Revenue Growth
n/a
P/S Ratio
-0.77
Revenue / Employee
-15.10K
Employees
78
Market Cap
906.60K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | -1.74M | -35.14M | - |
| Mar 31, 2024 | 33.40M | -8.44M | -20.18% |
| Mar 31, 2023 | 41.84M | 9.10M | 27.80% |
| Mar 31, 2022 | 32.74M | 16.52M | 101.87% |
| Mar 31, 2021 | 16.22M | 3.72M | 29.79% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ayurcann Holdings | 31.28M |
| Adastra Holdings | 16.86M |
| Vencanna Ventures | 3.60M |
| Aequus Pharmaceuticals | 918.47K |
| Ovation Science | 63.82K |
| Genix Pharmaceuticals | 68.00 |